One-Time gene therapy could free hemophilia patients from frequent infusions

NCT ID NCT04323098

First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 28 times

Summary

This study tested a one-time gene therapy (valoctocogene roxaparvovec) in 22 adults with severe hemophilia A. The goal was to help their bodies produce their own clotting factor VIII, reducing or stopping the need for regular factor infusions. Participants also received steroids to manage immune reactions. Results showed increased factor VIII levels and less bleeding, but long-term effects and need for ongoing monitoring remain.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Alfred Hospital

    Melbourne, Australia

  • Campinas University Clinical Hospital

    Campinas, Brazil

  • Changhua Christian Medical Foundation Changhua Christian Hospital

    Changhua, Taiwan

  • Fiona Stanley Hospital

    Perth, Australia

  • Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

    São Paulo, Brazil

  • Nationwide Children's Hospital

    Columbus, Ohio, 43205, United States

  • Royal Brisbane and Women's Hospital

    Brisbane, Australia

  • Royal Prince Alfred Hospital

    Sydney, Australia

  • Taichung Veterans General Hospital

    Taichung, Taiwan

  • The Royal Adelaide Hospital

    Adelaide, Australia

  • University of California Davis Health

    Sacramento, California, 95817, United States

  • Washington University School of Medicine

    St Louis, Missouri, 63110, United States

Conditions

Explore the condition pages connected to this study.